This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Belgian anti-trust regulators are probing Roche over concerns that the drug company took steps to delay the entry of biosimilar versions of two of its cancer medicines. In a brief statement , the Belgian Competition Authority alleged that Roche offered financial incentives to hospitals between 2017 and 2020 to deter them from considering competitive bids from other pharmaceutical companies that could supply similar medicines.
What are the top 3 trends that defined pharma manufacturing in India and globally in 2024? In 2024, the pharmaceutical manufacturing landscape underwent transformative changes, driven by technological innovations, regulatory adaptations, and evolving global demands. The following trends not only shaped the sector then but also set the stage for the future of pharma manufacturing, both in India and globally.
In May 2024, the Massachusetts Department of Public Health released a troubling report on a cluster of HIV infections, with more than 200 new cases since 2018 attributable to injection drug use in the Boston region. These findings have national implications: Similar HIV outbreaks have been described nationwide during the overdose crisis, including in West Virginia , Indiana , and Ohio.
NHS England (NHSE) will be scrapped and brought back into the Department of Health and Social Care (DHSC) 'to put an end to the duplication resulting from two organisations doing the same job', the government has said today. Prime Minister Sir Kier Starmer set out major reforms today, which will include the dissolution of NHSE […] The post NHS England to be scrapped with funding 'reinvested into frontline services' appeared first on The Pharmacist.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Half of every dollar spent on medicines goes to entities that don’t make medicine—like pharmacy benefit managers (PBMs) and insurers who are aggressively consolidating their control over health care and hospitals, clinics and for-profit pharmacies in the 340B markup program. As entities in the supply chain that don’t make medicine are increasingly using medicines to subsidize other parts of their business, patients and employers face increasing costs and barriers to accessing c
HHS head Robert F. Kennedy Jr. has long been an opponent of pharma influence in government. U.S. lawmakers are asking whether unofficial Mar-a-Lago meetings point to a change of heart.
217
217
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
HHS head Robert F. Kennedy Jr. has long been an opponent of pharma influence in government. U.S. lawmakers are asking whether unofficial Mar-a-Lago meetings point to a change of heart.
For the Rev. Beth Stotts, death is a natural part of her ministry. A major aspect of her job is guiding her congregants through their most vulnerable moments from birth throughout life. The struggles she has seen in her community led her to seek more training to help people face death, and in 2022 she added another credential to her spiritual one: end-of-life doula.
Money to develop IT systems to support the roll-out of Pharmacy First was 'not well spent', pharmacist and MP Sadik Al-Hassan has suggested. The Labour MP for North Somerset was speaking at a roundtable focusing on community pharmacy technology in parliament yesterday when he was asked by The Pharmacist for his views on the IT […] The post Pharmacy First IT funding 'not well spent', says pharmacist MP appeared first on The Pharmacist.
H.E.L Group, a global developer and manufacturer of laboratory tools for process optimisation, safety, and scale-up, has entered into a research agreement with the Institute of Chemical Technology (ICT) in Mumbai. The three-year strategic alliance aims to advance process safety in the chemical synthesis industry. The collaboration will focus on H.E.Ls Process Safety Hub alongside ICT Mumbais academic and research expertise in chemical sciences, engineering, and related fields.
Health care practitioners (HCPs), and patients too, are sounding the alarm on unnecessary barriers in the system that can negatively impact patients’ access to quality care according to a new survey of HCPs and patients. Specifically, HCPs raised concerns over how pharmacy benefit managers (PBMs) and insurers inappropriately use utilization management tools, like prior authorization, to deny or delay care, ultimately harming the patient and impacting patient access to care.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Introduction In todays competitive pharmaceutical landscape, marketing strategies must evolve to meet changing customer expectations. Are you still relying on traditional marketing tactics, or have you embraced a more dynamic, omnichannel marketing approach? With healthcare providers (HCPs) and patients engaging across multiple digital and offline touchpoints, pharma brands that fail to adapt risk losing valuable market share.
Reports of a new federal plan to study whether there’s a link between vaccines and autism could serve as an early test of the commitments Sen. Bill Cassidy (R-La.) said he received from Robert F. Kennedy Jr. in exchange for his support for RFK Jr.’s confirmation as Health and Human Services secretary. On Friday, multiple news outlets reported that the Centers for Disease Control and Prevention was planning the study.
A daily pill has been approved by NICE for treating some women with endometriosis after initially being rejected. It is estimated around 1,000 patients a year will be able to access the treatment called relugolixestradiolnorethisterone (also known as relugolix combination therapy or Ryeqo). The turnaround from NICE came after the company provided new evidence on […] The post NICE approves daily pill for endometriosis where other treatments have failed appeared first on The Pharmacist.
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Eluxadoline Tablets, 75 mg and 100 mg (USRLD: Viberzi Tablets, 75 mg and 100 mg). Eluxadoline is a mu-opioid receptor agonist, indicated in adults for the treatment of irritable bowel syndrome with diarrhoea (IBS-D). Eluxadoline tablets will be produced at Zydus Lifesciences (SEZ), Ahmedabad.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Table of Contents The Impact of a Pharma Ad Ban on TV Digital Marketing as a Primary Alternative Leveraging Data-Driven Advertising Strategies Strengthening Direct-to-Consumer (DTC) Engagement The Impact of a Pharma Ad Ban on TV The potential for a pharma ad ban on TV has sparked intense discussions among marketing executives. If regulations change, pharmaceutical brands must rethink their advertising strategies to maintain visibility and patient engagement.
A new biotech is raising money to develop a drug believed to be capable of starving cancer cells, based on research out of lauded cancer researcher Bert Vogelstein’s lab. The Boston-based company, Cage Pharma, has already received funding from Catalio Capital Management and hopes to raise up to $35 million in a Series A round, according to a person with knowledge of the company’s plans.
Community pharmacy leaders have expressed hope that the government's decision to abolish NHS England (NHSE) will mean more funding can be redirected to community pharmacy. Meanwhile, the sector's negotiator has pledged to work with 'whatever new structures and teams' are in place, while continuing to be 'fully focused' on current funding negotiations.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
A recent study published in Springer Medizin has identified insulinoma-associated protein 2 autoantibody (IA-2A) positivity as a significant biomarker for disease progression in individuals at risk of type 1 diabetes (T1D). The findings are particularly relevant as the T1D market undergoes a transformation driven by advancements in predictive diagnostics and disease-modifying therapies.
This initiative is stated to be a part of the company’s Phase I contract development and manufacturing organisation (CDMO) growth strategy. In response to the growing need for dependable production in the US, the expanded facility will help the company to enhance capacity for suspension, liquid, semi-solid, as well as suppository drug products.
Tuesday marked the fifth anniversary of the World Health Organization declaring Covid-19 a global pandemic. For science writer Carl Zimmer, a columnist for the New York Times, covering Covid meant “watching [scientists] figuring out this disease in real time.” Notably, “there were a lot of mysteries about it. I was really struck as, as others were, by how strange it was that, that the just a fundamental question of how Covid spread was so unclear and was leading to so much a
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
By Sara W. Koblitz Integral to the careful balance Congress struck when passing the Hatch-Waxman Amendments, the patent term extension (PTE) is intended to restore patent life that was consumed during regulatory review of an FDA-regulated product. Even though the PTE provisions established in the Drug Price Competition and Patent Restoration Act are forty-plus years old, courts are still grappling with questions about how to best implement the Patent Term Extension.
Switzerland-based Tenthpin Management Consultants has announced the launch of Tenthpin AI Labs (TAIL) in Hyderabad, creating a Global Centre of Excellence for AI-driven transformation in the Life Sciences sector. TAIL aims to help pharmaceutical, MedTech, biotech, and research organisations differentiate between AI hype and real value. By leveraging India’s technology talent and Hyderabads position as a life sciences hub, Tenthpin seeks to accelerate AI adoption across the drug life cycle,
NICE has recommended the first daily oral pill on the NHS to treat endometriosis. The new final draft guidance from NICE follows its earlier negative recommendation of relugolix estradiolnorethisterone (Ryeqo) relugolix combination therapy for this indication. The treatment offers key benefits including its administration by patients at home. “Instead of travelling to clinics for injections, there is now a daily tablet that can be taken at home,” stated Helen Knight , Director of Med
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
245 
Let's personalize your content